The Johns Hopkins University School of Medicine
Baltimore, MD, United States
Maximilian F. Konig is an Assistant Professor of Medicine in the Division of Rheumatology and Ludwig Center for Cancer Genetics and Therapeutics at the Johns Hopkins University School of Medicine. Dr. Konig received his medical degree from Charité – Universitätsmedizin Berlin and Humboldt-Universität zu Berlin in Germany. He completed residency training in Internal Medicine in the Stanbury Physician-Scientist Pathway at Massachusetts General Hospital, Harvard Medical School, and fellowship training in Clinical and Molecular Rheumatology at Johns Hopkins Hospital. His research program is focused on developing and advancing precision T cell therapies for the treatment of autoimmune rheumatic disease and cancer.
10F107: Global Priorities, Opportunities and Challenges in Rheumatology Research
Friday, November 10, 2023
3:15 PM – 4:15 PM PT
Disclosure(s): Argenx: Consultant (Terminated); ManaT Bio: Intellectual Property/Patents (Ongoing); Revel Pharmaceuticals: Consultant (Ongoing); Sanofi group: Consultant (Terminated)
13M141: Abstracts: Antiphospholipid Syndrome (1603–1608)
Monday, November 13, 2023
2:00 PM – 3:30 PM PT
Disclosure(s): Argenx: Consultant (Terminated); ManaT Bio: Intellectual Property/Patents (Ongoing); Revel Pharmaceuticals: Consultant (Ongoing); Sanofi group: Consultant (Terminated)
13M160: The World Is Your Oyster: Publishing Pearls from Editors
Monday, November 13, 2023
4:00 PM – 5:00 PM PT
Disclosure(s): Argenx: Consultant (Terminated); ManaT Bio: Intellectual Property/Patents (Ongoing); Revel Pharmaceuticals: Consultant (Ongoing); Sanofi group: Consultant (Terminated)
14T104: CARs as "Drivers" of Precision Cellular Immunotherapies for Autoimmune Diseases
Tuesday, November 14, 2023
7:30 AM – 8:30 AM PT
Disclosure(s): Argenx: Consultant (Terminated); ManaT Bio: Intellectual Property/Patents (Ongoing); Revel Pharmaceuticals: Consultant (Ongoing); Sanofi group: Consultant (Terminated)